Community curated by people like you

insitro stories

Oct 15, 2026

AstraZeneca partners with insitro on $40 million AI drug discovery deal

AstraZeneca has teamed up with AI biotech company insitro to discover and develop new treatments for difficult-to-treat liver and heart conditions, with the British drugmaker announcing the partnership on Tuesday.

Oct 15, 2026·2 sources

00

Top claims

▪AstraZeneca Executive Vice President Sharon Barr stated that pairing artificial intelligence tools with experienced scientists allows AstraZeneca to test fewer molecules in the lab, reduce guesswork, and accelerate drug discovery
▪AstraZeneca secured exclusive worldwide rights to advance programs identified through its October 15, 2026 partnership with insitro and will fund and run all clinical development, regulatory work, and commercialization activities
▪AstraZeneca Executive Vice President Sharon Barr stated on October 15, 2026, that identifying target pathways early using cellular systems allows AstraZeneca to discover novel targets before they enter the public domain

Topics

Longevity biotech founders AI for developers

Related entities